Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultravate and Lac-Hydrin in Psoriasis Treatment and Maintenance
NCT01111123Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jan 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Halobetasol propionate 0.05% lotion in plaque psoriasis, sponsored by Icahn School of Medicine at Mount Sinai. Started Jan 2009; status: completed.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01111123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111123.